...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics did not respond to invitatations in this one

Imtesty, I would love to think that Zenith is in play.... reason for  Zenith not responding  but with this  Management team, i would lend to think they  probably forgot to respond  and didn't respond in time. LOL

waiting 9 years on Zenith E  to be surprised with some really good news on the business side of things, Science side is all good to this point   , i guess 1 day we all will one way or another , godd or bad

Share
New Message
Please login to post a reply